Not applicableStudy completedNCT04749810What this trial is testingObservational Study of Elizaria® in aHUS PatientsWho this might be right forAtypical Hemolytic Uremic SyndromeaHUS AO GENERIUM 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05684159What this trial is testingStudy of NM8074 in Patients with AHUS with Evidence of Ongoing Thrombotic MicroangiopathyWho this might be right forAHUS - Atypical Hemolytic Uremic Syndrome NovelMed Therapeutics 12
Early research (Phase 1)WithdrawnNCT03275792What this trial is testingShiga Toxin Producing Escherichia Coli (STEC) Volume ExpansionWho this might be right forHemolytic-Uremic Syndrome University of Calgary
Not applicableUnknownNCT03494595What this trial is testingThromboelastometry as a Predictor of Thrombotic Complications During Pediatric Recipient Liver TransplantationWho this might be right forPediatric Liver Transplantation Assiut University 20
Not applicableUnknownNCT05301829What this trial is testingThrombin Generation Assay to Assess Thrombotic Risk in Nephrotic PatientsWho this might be right forNephrotic Syndrome Assistance Publique - Hôpitaux de Paris 75
Post-approval studies (Phase 4)Study completedNCT04409834What this trial is testingPrevention of Arteriovenous Thrombotic Events in Critically-Ill COVID-19 Patients TrialWho this might be right forCOVID-19Venous ThromboembolismArterial Thrombosis The TIMI Study Group 390
Testing effectiveness (Phase 2)UnknownNCT00531089What this trial is testingRituximab in Patients With Relapsed or Refractory TTP-HUSWho this might be right forThrombotic Thrombocytopenic PurpuraHemolytic Uremic Syndrome Hamilton Health Sciences Corporation 60
Not applicableStudy completedNCT01406288What this trial is testingOutbreak of Hemolytic Uremic Syndrome Linked to Escherichia Coli of Serotype O104:H4Who this might be right forHemolytic-uremic SyndromeEscherichia Coli Infections University Hospital, Bordeaux 9
Not applicableStudy completedNCT06038682What this trial is testingMonitoring Anticoagulation in Patients on ECMO for Severe Lung FailureWho this might be right forARDSCOVID-19 University Hospital Ostrava 100
Large-scale testing (Phase 3)Looking for participantsNCT05935215What this trial is testingEfficacy and Safety of Switching From Anti-C5 Antibody Treatment to Iptacopan Treatment in Study Participants With Atypical Hemolytic Uremic Syndrome (aHUS)Who this might be right forAtypical Hemolytic Uremic Syndrome Novartis Pharmaceuticals 50
Testing effectiveness (Phase 2)Study completedNCT00838513What this trial is testingOpen Label Controlled Trial of Eculizumab in Adult Patients With Plasma Therapy-sensitive Atypical Hemolytic Uremic Syndrome (aHUS)Who this might be right forAtypical Hemolytic Uremic Syndrome Alexion Pharmaceuticals, Inc. 15
Testing effectiveness (Phase 2)Study completedNCT00844428What this trial is testingOpen Label Controlled Trial of Eculizumab in Adolescent Patients With Plasma Therapy-Sensitive aHUSWho this might be right forAtypical Hemolytic Uremic Syndrome Alexion Pharmaceuticals, Inc. 5
Testing effectiveness (Phase 2)Study completedNCT02222545What this trial is testingSafety and Efficacy Study of OMS721 in Patients With Thrombotic MicroangiopathiesWho this might be right forThrombotic Microangiopathies Omeros Corporation 58
Not applicableActive Not RecruitingNCT06099236What this trial is testingA Prospective, Non-interventional, Observational Study of Presentation, Treatment Patterns and Outcomes in Atypical Hemolytic Uremic Syndrome PatientsWho this might be right forAtypical Hemolytic Uremic Syndrome(aHUS) AstraZeneca 367
Testing effectiveness (Phase 2)Study completedNCT00844844What this trial is testingOpen Label Controlled Trial of Eculizumab in Adolescent Patients With Plasma Therapy-Resistant aHUSWho this might be right forAtypical Hemolytic Uremic Syndrome Alexion Pharmaceuticals, Inc. 1
Not applicableLooking for participantsNCT06868823What this trial is testingProspective Observational Pilot Study of LMWH Versus UFH as ECMO Anticoagulation in Lung TransplantationWho this might be right forLung TransplantationExtracorporeal Membrane Oxygenation (ECMO)Anticoagulants and Bleeding Disorders University Hospital, Motol 40
Large-scale testing (Phase 3)UnknownNCT04570397What this trial is testingRavulizumab and COVID-19Who this might be right forCovid19Thrombotic MicroangiopathiesAcute Kidney Injury Brigham and Women's Hospital 32
Not applicableLooking for participantsNCT05996731What this trial is testingDeveloping a Pipeline to Employ RNA-Seq as a Complementary Diagnostic Tool in Rare DiseasesWho this might be right forAtypical Hemolytic Uremic SyndromeMembranoproliferative GlomerulonephritisAutosomal Dominant Polycystic Kidney+1 more Mario Negri Institute for Pharmacological Research 105
Not applicableUnknownNCT03574506What this trial is testingEculizumab Use in the Postpartum Period for the Treatment of Pregnancy Associated aHUS: A Case SeriesWho this might be right forAtypical Hemolytic Uremic SyndromePregnancy Fundación Grupo de Investigación en Cuidados Intensivos y Obstetricia 50
Testing effectiveness (Phase 2)Looking for participantsNCT06792643What this trial is testingCangrelor on Top of anticoagUlation in Patients With myocaRdial Infarction-related Cardiogenic Shock/Cardiac Arrest receiVIng VA-ECMOWho this might be right forCardiogenic ShockExtracorporeal Membrane Oxygenation ComplicationPlatelet Dysfunction IRCCS San Raffaele 50